Prosec Protection Systems Handed 483 for Process Validation Lapses
Prosec Protection Systems, a maker of umbilical clamps, received a Form 483 for various process validation deviations at its Lakewood, N.J., plant.
Prosec, also known as McRoberts Security Technologies, does not test its clamps for assurance of stability, nor does it accurately interpret, document or review its sterility testing procedures prior to shipment, the form states.
Sterility cycle reports are supposed to be reviewed and approved, but numerous cycles passed in 2011 without such reviews or approvals, FDA investigators said.
Lakewood staff also broke from company protocol on sterilization validation runs. For example, a final validation report for an interim run that failed for “temperature out of range” provided no rationale for not running consecutive cycles. The failure also was not investigated or evaluated, according to the form.
What hotspots in your operation could prompt an FDA inspector to issue you a Form 483?
You can wait until the inspectors arrive to find out. Or, you can jump ahead by learning exactly what’s triggering citations in other companies and fixing your similar vulnerabilities before the inspector arrives.
In one convenient source, this report provides an authoritative reference collection of the most newsworthy Form 483s issued recently to device manufacturers, including insights and analysis on what the inspections mean regarding everything from quality assurance to your relationships with service providers.
Don’t wait another moment to get this powerful tool in the your team’s hands. Order today.
The FDA's new enforcement plan makes one thing clear: Developing a successful CAPA program has never been more important. But creating an FDA-proof CAPA isn’t easy. If only you could pick the brain of someone who is coping successfully with CAPA — the best and the brightest, an industry leader who has devised programs, procedures and solutions that have put companies out in front with the FDA. Well, you can. Register today.Read More
Come for this valuable opportunity to hear FDA officials discuss regulatory plans and objectives — and ask questions you need answered; learn from device industry experts, consultants and other experts with actionable tips and strategies you can take straight back to the office; and network with other professionals who understand your challenges; share war stories and insights over a drink. Register Today.Read More
The FDA’s cadre of freshly trained inspectors — many of whom come directly from industry — and increased focus on specialized inspections are making it harder than ever to predict the outcome of your next FDA inspection. Unless, of course, you have Surviving an FDA Inspection at your fingertips. If you could spend less than $400 to get your drug manufacturing facility fully prepared to face a tough inspection by the FDA, would you even hesitate? ... Of course not!